New technology platforms in the development of vaccines for the future.
Glück
R
R
Berna Biotech Ltd., Berne, Switzerland. reinhard.glueck@bernabiotech.com
D005544:Forecasting; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000276:immunology; D006515:Hepatitis B virus / Q000276:immunology; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000276:immunology; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control*; D009975:Orthomyxoviridae / Q000276:immunology; D022721:Vaccines, Virosome / Q000008:administration & dosage* / Q000096:biosynthesis
D017325:Hepatitis B Vaccines; D007252:Influenza Vaccines; D022721:Vaccines, Virosome